annual retained earnings:
-$148.92M+$673.73M(+81.90%)Summary
- As of today (June 1, 2025), AGIO annual retained earnings is -$148.92 million, with the most recent change of +$673.73 million (+81.90%) on December 31, 2024.
- During the last 3 years, AGIO annual retained earnings has risen by +$89.84 million (+37.63%).
- AGIO annual retained earnings is now -176.12% below its all-time high of -$53.94 million, reached on December 31, 2011.
Performance
AGIO Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$238.21M-$89.29M(-59.96%)Summary
- As of today (June 1, 2025), AGIO quarterly retained earnings is -$238.21 million, with the most recent change of -$89.29 million (-59.96%) on March 31, 2025.
- Over the past year, AGIO quarterly retained earnings has increased by +$665.99 million (+73.65%).
- AGIO quarterly retained earnings is now -872.17% below its all-time high of $30.85 million, reached on March 31, 2021.
Performance
AGIO quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AGIO Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +81.9% | +73.7% |
| 3 y3 years | +37.6% | +28.6% |
| 5 y5 years | +90.2% | +84.7% |
AGIO Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +81.9% | -354.6% | +76.2% |
| 5 y | 5-year | at high | +91.9% | -872.2% | +87.1% |
| alltime | all time | -176.1% | +91.9% | -872.2% | +87.1% |
AGIO Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$238.21M(+60.0%) |
| Dec 2024 | -$148.92M(-81.9%) | -$148.92M(+184.2%) |
| Sep 2024 | - | -$52.40M(-94.8%) |
| Jun 2024 | - | -$1.00B(+10.6%) |
| Mar 2024 | - | -$904.20M(+9.9%) |
| Dec 2023 | -$822.65M(+74.8%) | -$822.65M(+13.2%) |
| Sep 2023 | - | -$726.71M(+14.4%) |
| Jun 2023 | - | -$635.38M(+15.2%) |
| Mar 2023 | - | -$551.58M(+17.2%) |
| Dec 2022 | -$470.56M(+97.1%) | -$470.56M(-7.2%) |
| Sep 2022 | - | -$507.09M(+19.2%) |
| Jun 2022 | - | -$425.34M(+27.5%) |
| Mar 2022 | - | -$333.53M(+39.7%) |
| Dec 2021 | -$238.76M(-87.0%) | -$238.76M(+65.7%) |
| Sep 2021 | - | -$144.13M(+160.3%) |
| Jun 2021 | - | -$55.37M(-279.5%) |
| Mar 2021 | - | $30.85M(-101.7%) |
| Dec 2020 | -$1.84B(+21.6%) | -$1.84B(+5.6%) |
| Sep 2020 | - | -$1.75B(+6.0%) |
| Jun 2020 | - | -$1.65B(+5.8%) |
| Mar 2020 | - | -$1.56B(+2.7%) |
| Dec 2019 | -$1.52B(+37.2%) | -$1.52B(+7.2%) |
| Sep 2019 | - | -$1.41B(+8.1%) |
| Jun 2019 | - | -$1.31B(+9.2%) |
| Mar 2019 | - | -$1.20B(+8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -$1.10B(+38.4%) | -$1.10B(+9.1%) |
| Sep 2018 | - | -$1.01B(+10.3%) |
| Jun 2018 | - | -$918.17M(+8.1%) |
| Mar 2018 | - | -$849.43M(+6.4%) |
| Dec 2017 | -$798.06M(+65.2%) | -$798.06M(+12.4%) |
| Sep 2017 | - | -$709.78M(+12.2%) |
| Jun 2017 | - | -$632.64M(+15.1%) |
| Mar 2017 | - | -$549.56M(+13.7%) |
| Dec 2016 | -$483.15M(+69.7%) | -$483.15M(+13.2%) |
| Sep 2016 | - | -$426.67M(+17.3%) |
| Jun 2016 | - | -$363.83M(+18.2%) |
| Mar 2016 | - | -$307.88M(+8.1%) |
| Dec 2015 | -$284.68M(+70.5%) | -$284.68M(+16.6%) |
| Sep 2015 | - | -$244.06M(+19.8%) |
| Jun 2015 | - | -$203.80M(+18.6%) |
| Mar 2015 | - | -$171.91M(+3.0%) |
| Dec 2014 | -$166.95M(+47.2%) | -$166.95M(+19.0%) |
| Sep 2014 | - | -$140.28M(-2.6%) |
| Jun 2014 | - | -$143.99M(+14.6%) |
| Mar 2014 | - | -$125.69M(+10.8%) |
| Dec 2013 | -$113.44M(+53.2%) | -$113.44M(+12.3%) |
| Sep 2013 | - | -$101.06M(+12.4%) |
| Jun 2013 | - | -$89.89M(+10.6%) |
| Mar 2013 | - | -$81.27M(+9.8%) |
| Dec 2012 | -$74.04M(+37.3%) | -$74.04M |
| Dec 2011 | -$53.94M | - |
FAQ
- What is Agios Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual retained earnings year-on-year change?
- What is Agios Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly retained earnings year-on-year change?
What is Agios Pharmaceuticals annual retained earnings?
The current annual retained earnings of AGIO is -$148.92M
What is the all time high annual retained earnings for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual retained earnings is -$53.94M
What is Agios Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, AGIO annual retained earnings has changed by +$673.73M (+81.90%)
What is Agios Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of AGIO is -$238.21M
What is the all time high quarterly retained earnings for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly retained earnings is $30.85M
What is Agios Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, AGIO quarterly retained earnings has changed by +$665.99M (+73.65%)